title: Dopamine agonists and risk: impulse control disorders in Parkinson's disease.
abstract: Impulse control disorders are common in Parkinson's disease, occurring in 13.6% of patients. Using a pharmacological manipulation and a novel risk taking task while performing functional magnetic resonance imaging, we investigated the relationship between dopamine agonists and risk taking in patients with Parkinson's disease with and without impulse control disorders. During functional magnetic resonance imaging, subjects chose between two choices of equal expected value: a 'Sure' choice and a 'Gamble' choice of moderate risk. To commence each trial, in the 'Gain' condition, individuals started at $0 and in the 'Loss' condition individuals started at -$50 below the 'Sure' amount. The difference between the maximum and minimum outcomes from each gamble (i.e. range) was used as an index of risk ('Gamble Risk'). Sixteen healthy volunteers were behaviourally tested. Fourteen impulse control disorder (problem gambling or compulsive shopping) and 14 matched Parkinson's disease controls were tested ON and OFF dopamine agonists. Patients with impulse control disorder made more risky choices in the 'Gain' relative to the 'Loss' condition along with decreased orbitofrontal cortex and anterior cingulate activity, with the opposite observed in Parkinson's disease controls. In patients with impulse control disorder, dopamine agonists were associated with enhanced sensitivity to risk along with decreased ventral striatal activity again with the opposite in Parkinson's disease controls. Patients with impulse control disorder appear to have a bias towards risky choices independent of the effect of loss aversion. Dopamine agonists enhance sensitivity to risk in patients with impulse control disorder possibly by impairing risk evaluation in the striatum. Our results provide a potential explanation of why dopamine agonists may lead to an unconscious bias towards risk in susceptible individuals.
authors: Behavioural and Clinical Neurosciences Institute, Department of Experimental Psychology, Downing Site, University of Cambridge, Cambridge CB2 3EB, UK. vv247@cam.ac.uk
authors: Valerie
authors: V
authors: Voon
authors: Jennifer
authors: J
authors: Gao
authors: Christina
authors: C
authors: Brezing
authors: Mkael
authors: M
authors: Symmonds
authors: Vindhya
authors: V
authors: Ekanayake
authors: Hubert
authors: H
authors: Fernandez
authors: Raymond J
authors: RJ
authors: Dolan
authors: Mark
authors: M
authors: Hallett
references: J Clin Psychiatry. 1994 Jun;55(6):242-8
references: 8071278
references: Nat Neurosci. 2005 Sep;8(9):1234-40
references: 16116445
references: Neurology. 2010 Nov 9;75(19):1711-6
references: 20926784
references: Cogn Affect Behav Neurosci. 2008 Dec;8(4):348-54
references: 19033233
references: Neuroimage. 2002 Apr;15(4):870-8
references: 11906227
references: Neuron. 2005 Sep 1;47(5):763-70
references: 16129404
references: J Neurosci. 2008 Mar 12;28(11):2745-52
references: 18337404
references: Nat Rev Neurosci. 2009 Jan;10(1):59-70
references: 19096369
references: Neuron. 2010 Jan 14;65(1):135-42
references: 20152119
references: Psychopharmacology (Berl). 2007 Apr;191(3):507-20
references: 17031711
references: Mov Disord. 2010 Oct 15;25(13):2203-10
references: 20721918
references: Psychopharmacology (Berl). 2010 Jan;207(4):645-59
references: 19838863
references: Mov Disord. 2010 Aug 15;25(11):1660-9
references: 20589879
references: Neuron. 2001 Feb;29(2):537-45
references: 11239442
references: Arch Neurol. 2010 May;67(5):589-95
references: 20457959
references: Neuron. 2006 Aug 3;51(3):381-90
references: 16880132
references: J Neurophysiol. 2007 Feb;97(2):1621-32
references: 17122317
references: Science. 2003 Mar 21;299(5614):1898-902
references: 12649484
references: Brain. 2009 May;132(Pt 5):1376-85
references: 19346328
references: Biol Psychiatry. 2010 Apr 15;67(8):702-6
references: 19914604
references: Neurosci Biobehav Rev. 2006;30(1):1-23
references: 15935475
references: Arch Neurol. 2007 Aug;64(8):1089-96
references: 17698698
references: Eur J Neurol. 2010 Jan;17(1):97-102
references: 19780806